Dawn Health and Merck are collaborating to support Growth Disorders care

Copenhagen

4th June 2024

 

We are thrilled to share that we are working with the leading global pharmaceutical company, Merck, to work together on a digital solution for Growth Hormone Disorders (GHD).

 

Over the next two years, we will join forces to deliver a cutting-edge, user-centric digital platform, designed to help improve the lives of tens of thousands of patients across more than 40 countries. By harnessing the latest AI technologies, our collaboration will also involve exploring the integration of features such as growth predictions and advanced personalization into the digital product. We are excited about AI and its potential for impact on user experience, adoption, adherence, and treatment outcomes.

 

We are so proud to have been selected and entrusted by Merck, who are pioneers in the field of GHD and digital health. The digital solution will provide support to children and young adults living with GHD, as well as providing tools and support to their caregivers, both at home and in a clinical setting. 

 

Sharing our commitment to improving patient lives, our work with Merck will focus on patient-centricity to deliver an intuitive, engaging product that supports users and caregivers throughout their treatment journey. This means speaking with patients to truly understand their unmet needs and how the solution can best address these, as well as hearing from caregivers and healthcare professionals about how to best empower and support those living with GHD.

 

Thank you to the whole team at Merck and Dawn Health for a collaboration that is already off to a strong start, with workshops and inspiring discussions happening! We are thrilled to be embarking on this journey together and to be working with the driven team at Merck to improve the lives of people living with GHD.

About Dawn Health

Dawn Health is a global leader in digital health, specializing in the development of software as medical device (SaMD) and digital therapeutics (DTx). Partnering with pharmaceutical companies, Dawn Health accelerates the launch of digital solutions to change the lives of people with chronic conditions.